Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Shashi Nagaraj

Pediatric Nephrology Durham, NC Medical Doctor

NPI 1861476848 CMS profile 729923

2100 Erwin Rd, Durham, NC 27710

Open in the dashboard

General payments

$7,629

10 records reported · program years 2019–2025

Research payments

$12,750

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$129,145 paid to institutions, not to them · program years 2019–2022

Through program year 2025, Shashi Nagaraj of Durham, NC is reported in the CMS Open Payments database as having received $7,629 across 10 general payments and $12,750 in research payments paid to them. Separately, studies naming them as principal investigator received $129,145 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 92nd percentile of Pediatric Nephrology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,229 4
2023 General $5,369 4
2020 General $13 1
2019 General $18 1
2019 Research $12,750 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Shashi Nagaraj
  • Pediatric Nephrology median
  • Middle half of Pediatric Nephrology
  • National median

In program year 2025, general payments to Shashi Nagaraj were reported at $2,229. Among 327 Pediatric Nephrology profiles paid that year, the median was $131 and the middle half received between $47 and $474.

Show as a table
Year Shashi Nagaraj Pediatric Nephrology median Middle half National median
2019 $18 $123 $48–$353 $163
2020 $13 $146 $24–$2,251 $114
2021 $0 $138 $26–$1,371 $132
2022 $0 $93 $25–$427 $149
2023 $5,369 $105 $30–$375 $160
2024 $0 $123 $40–$481 $164
2025 $2,229 $131 $47–$474 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Novo Nordisk Inc $7,580 7 payments
  2. Novo Nordisk Health Care AG $18 1 payment
  3. La Jolla Pharmaceutical Company $18 1 payment
  4. Mallinckrodt Hospital Products Inc. $13 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $7,243 4 payments
  2. Food and Beverage $196 4 payments
  3. Travel and Lodging $178 1 payment
  4. Education $13 1 payment
Products named General payments · program years 2019–2025
  1. Rivfloza $2,229 4 payments
  2. GIAPREZA $18 1 payment
  3. ACTHAR $13 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Alexion Pharmaceuticals, Inc. $12,750 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

25

Median for Nephrology: 954

Drug cost

$62

Median for Nephrology: $127,050

Branded share of claims

0%

Median for Nephrology: 17.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Lisinopril Generic 14 $57
Amlodipine Besylate Generic 11 $5

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 9,003 Part D prescribers listed as Nephrology; they describe a distribution and say nothing about conduct.

Records

11 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatric Nephrology in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record